Iofina plc (LON:IOF – Get Free Report) crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 49.16 and traded as low as GBX 46. Iofina shares last traded at GBX 47.90, with a volume of 336,995 shares changing hands.
Analyst Ratings Changes
Separately, Canaccord Genuity Group reissued a “buy” rating and set a GBX 70 price objective on shares of Iofina in a research report on Friday, October 16th. One analyst has rated the stock with a Buy rating. Based on data from MarketBeat, Iofina has a consensus rating of “Buy” and a consensus price target of GBX 70.
Read Our Latest Report on Iofina
Iofina Trading Down 2.2%
The company has a 50 day simple moving average of GBX 52.32 and a 200 day simple moving average of GBX 49.16. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 10.80. The stock has a market capitalization of £91.90 million, a PE ratio of 10.64 and a beta of 0.96.
Iofina (LON:IOF – Get Free Report) last announced its earnings results on Monday, September 21st. The company reported GBX 1.80 earnings per share for the quarter. Iofina had a return on equity of 15.30% and a net margin of 12.91%. Analysts predict that Iofina plc will post 1.82 earnings per share for the current fiscal year.
Iofina Company Profile
Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.
Recommended Stories
- Five stocks we like better than Iofina
- Market Volatility Playbook: Trade the Noise, Get Paid to Ignore the Rest
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
Receive News & Ratings for Iofina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iofina and related companies with MarketBeat.com's FREE daily email newsletter.
